Due: February 15, 2024 This RPP is focused on the development of a software prototype that will allow a medical planner to assess the residual operational risk for a mission after layering in threat risk, Read More
DUE: February 28, 2024 SON Title:RED-003: Tools & Methodologies to Enable Automation of Testing for Components of Cyber-Physical SystemsRED-004: Tools for Vulnerability Assessment of Cyber-Physical SystemsRED-005: Non-Internet Protocol (IP) Traffic GenerationRED-006: Controlled Reception Pattern Antennas Read More
Due: February 2, 2024 Launch your electrifying journey into the future of innovation! Join the world’s largest multi-sector commercialization program for emerging deep technologies. Pitch your groundbreaking innovations and connect with top-tier corporate, investment, military Read More
Due: May 7, 2024 The purpose of this ISS National Lab Research Announcement (NLRA) is to solicit proposals focused on flight investigations within applied research and development, translational medicine, technology readiness level maturation, and technology demonstration to Read More
DUE: February 28, 2024 This Concept supports clinical studies applications to study psychedelic treatment administration paradigms, assess the role of psychotherapy in its administration, and describe and assess the range of clinical outcomes, including downstream Read More
DUE: February 22, 2024 The purpose of this NOFO is to provide support for applications for IND-enabling studies for the development of a novel in vivo genome editing therapeutic platform (genome editor plus delivery system) Read More
DUE: February 20, 2024 This RFA will solicit applications for a pivotal phase 3 clinical trial to determine the efficacy of FDA approved monoclonal antibody therapy compared to placebo in diverse “mixed dementia” populations with Read More
DUE: February 16, 2024 The 2023 update to theNational Artificial Intelligence Research and Development Strategic Plan,informed by visioning activities in the scientific community as well as interaction with the public, identifies as its first strategic Read More
DUE: February 15, 2024 \This FOA is a key element of NIMHs set of FOAs to support clinical trials research across the intervention development and testing pipeline. The FOA supports (1) clinical trials to test Read More
DUE: February 15, 2024 NIMH requires an experimental therapeutics approach for the development and testing of therapeutic interventions, in which studies both evaluate the clinical effect of an intervention and generate information about the mechanisms Read More
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2024 - All rights reserved.